Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01476176 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetic Study of an Experimental Paracetamol Formulation
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01476176 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 30 participants.
The verdict
NCT01476176, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This PK study is designed to show bioequivalence between the study treatments.
Interventions
- DRUG Experimental paracetamol
- DRUG Paracetamol marketed formulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01476176
The ClinicalTrials.gov registry entry for NCT01476176 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Experimental paracetamol is the first listed.
NCT01476176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01476176 about?
NCT01476176 is a clinical study titled "A Pharmacokinetic Study of an Experimental Paracetamol Formulation". This PK study is designed to show bioequivalence between the study treatments.
What is the current status of trial NCT01476176?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2009-07. Estimated completion is 2009-08.
What interventions are being tested in trial NCT01476176?
The interventions under investigation include: Experimental paracetamol (DRUG), Paracetamol marketed formulation (DRUG).
Who is sponsoring clinical trial NCT01476176?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.